Search Results
Mar 10, 2026, 08:05 ET NEO Wins NAHB Global Innovation Gold Award, Highlighting Alignment Between Homebuilders and REALTORS®
professionals, enhancing the client experience and shaping the future of our industry."Together, recognition from both NAHB and NAR reflects a rare convergence within the housing ecosystem: builders and agents increasingly recognizing the same operational need — a reliable infrastructure layer that
More news about: New Estate Only, Inc.
Mar 10, 2026, 08:03 ET Genomenon and Amicus Therapeutics Partner to Advance Fabry Disease Awareness and Diagnosis
widely used public archive of human genetic variants hosted by the National Center for Biotechnology Information (NCBI). Fabry disease is a rare, X-linked lysosomal storage disorder caused by deficiency of alpha-galactosidase A (α-Gal A), encoded by GLA. This leads to progressive accumulation
More news about: Genomenon
Mar 10, 2026, 08:03 ET Little Palm Island Announces Landmark Culinary Partnership with Chef Curtis Duffy and Executive Chef Rodrigo Albornoz
extraordinary settings in the world."I'm truly excited about this partnership with Little Palm Island and Chef Rodrigo," said Duffy. "It's a rare opportunity to bring our shared commitment to craft and ingredient‑driven cuisine to one of the most special destinations in the country. Together,
More news about: Little Palm Island
Mar 10, 2026, 08:00 ET Andelyn Biosciences Establishes The Andelyn Foundation to Support Families Living with Rare and Ultra-Rare Diseases
The Andelyn Foundation, a nonprofit organization dedicated to supporting families living with rare and ultra-rare diseases through awareness, fundraising, and compassionate community engagement.
More news about: Andelyn Biosciences
Mar 10, 2026, 08:00 ET Chris Duke joins RBL LLC leadership team as Operating Partner
Duke, a seasoned biopharmaceutical executive and former CEO of Gennao Bio, brings extensive experience in rare diseases, gene therapy, global commercialization, and company building that will be instrumental in RBL's mission to accelerate lifesaving therapies
More news about: RBL LLC
Mar 10, 2026, 08:00 ET METAMAG Demonstrates Auto-Tune Filter (AtF®) Technology During U.S. Army Operation Lethal Eagle
company specializing in advanced RF and electromagnetic spectrum technologies. The company develops Auto-Tune Filters® (AtF®), rare earth bias magnet-free RF circulators and isolators, and gyromagnetic nonlinear transmission line technologies designed to enable reliable operation
More news about: Metamagnetics
Mar 10, 2026, 08:00 ET Manulife Selects Akka to Operationalize Agentic AI within its Enterprise AI Platform
testament to our 15 years of enterprise scale and regulated industry experience," said Tyler Jewell, CEO of Akka. "The Manulife team demonstrates the rare understanding of what it really takes to deliver agentic AI on a global scale. Without consistent engineering practices that address a complex and continually
More news about: Manulife Financial Corporation
Mar 10, 2026, 08:00 ET Manulife Selects Akka to Operationalize Agentic AI within its Enterprise AI Platform
testament to our 15 years of enterprise scale and regulated industry experience," said Tyler Jewell, CEO of Akka. "The Manulife team demonstrates the rare understanding of what it really takes to deliver agentic AI on a global scale. Without consistent engineering practices that address a complex and continually
More news about: Manulife Financial Corporation
Mar 10, 2026, 07:30 ET Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that SGX945 (dusquetide) has been granted Promising Innovative Medicine (PIM) designation
More news about: SOLIGENIX, INC.
Mar 10, 2026, 07:00 ET Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up
observed in Becker natural history studies –– Data reinforce prior clinical findings of sevasemten in Becker, a rare disease with no approved treatments ––The GRAND CANYON placebo-controlled pivotal cohort is on track to readout in 4Q 2026
More news about: Edgewise Therapeutics
Mar 10, 2026, 07:00 ET Inc. Names Casap CEO and Co-Founder to Its 2026 Female Founders 500 List
transformed their industries and broken barriers along the way."We're building a future where trust is a given and fraud is rare," said Shanmugam. "Recognition like this reinforces that the industry is ready for change. For years, slow, painful dispute processes were just accepted
More news about: Casap
Mar 10, 2026, 06:59 ET Gas Mixtures Market worth $35.04 billion by 2030 - Exclusive Report by MarketsandMarkets™
increasingly being used in food packaging applications to lengthen shelf life and maintain the quality of a product. Nitrogen gases are less expensive than rare and special gases. They can be used with many other gases, allowing for the versatility to be used in a variety of other industries. Because of the
More news about: MarketsandMarkets
Mar 10, 2026, 06:05 ET Armadin Secures Record-Breaking $189.9M in Seed and Series A Funding to Combat the Era of AI-Driven Hyperattacks
machine speed. We believe that this is the only way to prepare for the coming wave of AI Hyperattacks." Armadin's founding team is a rare fusion of elite red teaming experts and AI researchers and engineers under the leadership of Kevin Mandia, who maintains deep, trusted relationships
More news about: Armadin
Mar 10, 2026, 06:00 ET Luxury for Less: Realtor.com® Report Reveals the Top Metros for More Accessible High-End Living
Numbers90th percentile = Entry-level luxury (top 10% of prices)95th percentile = High-end luxury99th percentile = Ultraluxury (often rare or custom properties)About Realtor.com®Realtor.com® pioneered online real estate and has been at the forefront
More news about: Realtor.com
Mar 10, 2026, 05:59 ET EQT Foundation opens applications for science grants to overcome the blood-brain barrier and transform CNS drug delivery
medicine, leaving hundreds of millions of patients with neurological disorders such as Alzheimer's disease, Parkinson's disease, brain tumors, ALS, and rare pediatric neurological conditions without effective treatments. Breakthroughs in BBB delivery have the potential to fundamentally transform outcomes
More news about: EQT
Mar 10, 2026, 04:26 ET Lundbeck appoints Chief AI Officer
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: H. Lundbeck A/S
Mar 10, 2026, 04:22 ET Lundbeck appoints Chief AI Officer
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: H. Lundbeck A/S
Mar 10, 2026, 02:00 ET Masterpieces of Craftsmanship, Gastronomy and Culture: "JAPAN SUI COLLECTION a Paris" Captivates 200 European Leaders at Le Royal Monceau
pioneering innovations--such as applying traditional lacquer to genuine leather, a concept entirely fresh to the European market--combined with the rare opportunity to hear the artist himself share the "untold stories" and passion behind his creations, delivered a profound, visceral impact. This firsthand
More news about: Cabinet Office, Government of Japan
Mar 10, 2026, 02:00 ET Masterpieces of Craftsmanship, Gastronomy and Culture: "JAPAN SUI COLLECTION a Paris" Captivates 200 European Leaders at Le Royal Monceau
pioneering innovations--such as applying traditional lacquer to genuine leather, a concept entirely fresh to the European market--combined with the rare opportunity to hear the artist himself share the "untold stories" and passion behind his creations, delivered a profound, visceral impact. This firsthand
More news about: Cabinet Office, Government of Japan
Mar 09, 2026, 21:30 ET NAVER D2SF Invests in Physical AI Startup 'Khameleon'
and Bear Robotics. The team has also participated in large-scale robotics projects — including the mass production of over 20,000 robots — giving them rare depth in both robotics development and commercialization.Donghoon Lee, CEO of Khameleon, said, "Cleaning is a universal necessity, yet core tasks
More news about: NAVER
Mar 09, 2026, 21:14 ET Argentina's President Milei Joined Yeshiva University's President for "Great Conversations with Rabbi Dr. Ari Berman"
students, the opportunity to hear directly from a leader confronting the realities of fiscal policy, monetary stability and institutional reform was both rare and invaluable.""It is a privilege to be welcomed by the Yeshiva University community," President Milei said. "Under Rabbi Berman's leadership,
More news about: Yeshiva University
Mar 09, 2026, 18:21 ET Lara Khouri, MBA, MPH, Named New Chief Executive Officer of Miller Children's & Women's Hospital
grew up in a family that advocated for people's health. Her father was an ophthalmologist, and her mother managed the practice."Lara brings a rare combination of strategic discipline, clinical understanding, and mission-driven leadership," says
More news about: Miller Children’s & Women’s Hospital
Mar 09, 2026, 17:59 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.So what:
More news about: THE ROSEN LAW FIRM, P. A.
Mar 09, 2026, 17:31 ET Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight
testing may identify actionable subsets, including MSI-high tumors, high tumor mutational burden, NTRK fusions, or DNA repair deficiencies. Even if rare, these subsets offer potential for durable responses with targeted therapies.Launch of Emerging Therapies: The dynamics of the NECs market
More news about: DelveInsight Business Research, LLP
Mar 09, 2026, 15:23 ET SLNO Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Against Soleno Therapeutics, Inc.
Therapeutics (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2025. Soleno is a pharmaceutical company focused on developing therapies for rare diseases. The Company's only commercial product is diazoxide choline extended-release tablets ("DCCR") for the treatment of hyperphagia in individuals
More news about: Robbins LLP